Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial

Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial

ContextFollowing total thyroidectomy and radioactive iodine (RAI) ablation, serum thyroglobulin levels should be undetectable to assure that patients are excellent responders and at very low risk of recurrence.ObjectiveTo assess the utility of stimulated (sTg) and non-stimulated (nsTg) thyroglobulin...

Full description

Bibliographic Details
Main Authors: Anwar A. Jammah, Afshan Masood, Layan A. Akkielah, Shaimaa Alhaddad, Maath A. Alhaddad, Mariam Alharbi, Abdullah Alguwaihes, Saad Alzahrani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Endocrinology
Subjects:
highly sensitive thyroglobulin
differentiated thyroid cancer
stimulated thyroglobulin
reclassification
dynamic risk assessment
DTC recurrence
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.603432/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2020.603432/full

Similar Items